Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright
09/05/2024 21:56
May 9 (Reuters) - eFFECTOR Therapeutics Inc EFTR.O :
* EFFECTOR THERAPEUTICS INC: ENTERED INTO AN AT THE MARKET
OFFERING AGREEMENT WITH H.C. WAINWRIGHT & CO., LLC
* EFFECTOR THERAPEUTICS: UNDER AGREEMENT, CO MAY, FROM TIME
TO
TIME, SELL SHARES OF CO'S COMMON STOCK HAVING OFFERING PRICE OF
UP TO $50 MILLION
* EFFECTOR THERAPEUTICS INC: TERMINATED ITS CONTROLLED
EQUITY
OFFERING SALES AGREEMENT, DATED SEPT 1, 2022, WITH CANTOR
FITZGERALD & CO
Source text for Eikon: ID:n0000950170-24-056912
Further company coverage: EFTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright